A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects

Summary

The purpose of this study is to evaluate the efficacy and safety of Nexagon® in subjects with Persistent Epithelial Defects (PED) originally caused by chemical burns.

Timeline

Start

2009-03

Primary completion

2009-11

Completion

2010-03

Outcome

Outcome not reported

Stopped (Enrollment): “Withdrawn prior to recruitment for business reasons.”

Drugs

Indications